Better Patient Outcomes with Epic Language Access Integration
Learn how to improve health outcomes and ensure compliance for individuals with Limited English Proficiency (LEP) with direct language access integration to the Epic Electronic Health Record (EHR) system.
Case Study: Multilingual Retail Marketing
New AI Content Creation Solutions for a Sports and Apparel Giant
Human Insight, Augmented by AI
Lionbridge Aurora AI™ is our approach to AI: guided by human insight and built into every solution we deliver. Our experts apply AI to scale your multilingual content and reach new audiences with culturally relevant, hyper-personalized experiences.
Executing multi-regional clinical trials requires especially efficacious communication throughout the full cycle of development. Accurate translations help trial sponsors reduce costs, errors, and inefficiencies. They also improve patient outcomes and experience. With Lionbridge, you’ll deliver optimal research and patient outcomes faster.
Lionbridge Life Sciences has decades of experience providing customized language solutions for clinical trials across all phases, therapeutic areas, indications, and diverse clinical trial participant populations. We bring deep subject matter expertise, rigorous quality control, and innovative technology. Select from our comprehensive portfolio of clinical study solutions to help you deliver accurate, compliant translations that ensure the best patient outcomes possible.
Discover how AI could enhance Life Sciences workflows, drug discovery and approval, and more.
Read More in Our Blog.
Meet clinical trial regulations and provide the public with clear, easily understood trial information to raise awareness and inform about clinical trial options.
Reach, recruit, and retain diverse pools of target trial participants by ensuring trial accessibility and inclusivity.
Generate robust clinical research data that reflect relevant, compelling outcomes to trial participants and target patient populations.
Employ plain language communication to disseminate clear, comprehensible trial results to global audiences.